SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...
HO CHI MINH CITY, Vietnam, Jan. 16, 2026 /PRNewswire/ -- For more than 40 years, Dewan Architects + Engineers has been shaping cities and destinations...
SHANGHAI, Jan. 19, 2026 /PRNewswire/ -- Over the past decade, China's electric vehicle (EV) industry has evolved from a niche experiment into a leading force...